BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

BioNews
Biotechnology, Pharmaceutical and Life Science News
search help

Search Results

Documents 1-25 out of 517 found
  Current Search:  anemia: 517     

HTML
100%
Undiagnosed Celiac Disease Associated With Nearly Quadrupled Mortality
Celiac disease, an immune system reaction to gluten in the diet, is over four times more common today than it was 50 years ago, according to findings of a Mayo Clinic study published this month in the journal Gastroenterology.

The study...

MediLexicon:  Jul 4 2009 7:54AM
Matching: anemia
Find similar documents
HTML
100%
Anemia increases PE mortality risk
MedWire News: Pulmonary embolism (PE) patients with low levels of hemoglobin (Hb) have a greater risk of dying than their counterparts without anemia, research suggests.

David Jimnez Castro (Ramn y Cajal Hospital, Madrid, Spain) and...

MedWire News:  Jul 3 2009 4:01PM
Matching: anemia
Find similar documents
HTML
100%
FDA approves new IV iron therapy for CKD
The drug is not yet approved for an oncology setting.

Print Email Discuss in our forum The FDA has approved ferumoxytol injection for intravenous use as an iron replacement therapy for the treatment of iron deficiency anemia in adult...

Hemonctoday:  Jul 3 2009 4:28PM
Matching: anemia
Find similar documents
HTML
100%
Undiagnosed Celiac Disease Associated With Nearly Quadrupled Mortality
Celiac disease, an immune system reaction to gluten in the diet, is over four times more common today than it was 50 years ago, according to findings of a Mayo Clinic study published this month in the journal Gastroenterology.

The study...

Medical News Today:  Jul 3 2009 11:35AM
Matching: anemia
Find similar documents
HTML
100%
Preoperative hemoglobin level as a predictor of survival after coronary artery bypass grafting. A comparison w
Study of how the preoperative hemoglobin level affects pt survival after CABG Comparison of late mortality for CABG pts vs general population Determination of early and late mortality of all consecutive pts undergoing isolated CABG January...
MDLinx:  Jul 3 2009 7:10AM
Matching: anemia
Find similar documents
HTML
100%
FDA Approves Feraheme' To Treat Iron Deficiency Anemia In Adult Chronic Kidney Disease Patients
AMAG Pharmaceuticals, Inc.

(NASDAQ:AMAG) announced that the U.S.

Food and Drug Administration (FDA) has granted marketing approval for Feraheme" (ferumoxytol) Injection for intravenous (IV) use as an iron replacement therapy for the...

Medical News Today:  Jul 2 2009 12:59PM
Matching: anemia
Find similar documents
HTML
100%
FDA Approves Feraheme To Treat Iron Deficiency Anemia In Adult Chronic Kidney Disease Patients
AMAG Pharmaceuticals, Inc.

(NASDAQ:AMAG) announced that the U.S.

Food and Drug Administration (FDA) has granted marketing approval for Feraheme (ferumoxytol) Injection for intravenous (IV) use as an iron replacement therapy for the...

Medical News Today:  Jul 2 2009 11:03AM
Matching: anemia
Find similar documents
HTML
100%
FDA Approves Feraheme to Treat Iron Deficiency Anemia in Adult Chronic Kidney Disease Patients
- AMAG Pharmaceuticals, Inc.

(NASDAQ:AMAG) today announced that the U.S.

Food and Drug Administration (FDA) has granted marketing approval for Feraheme (ferumoxytol) Injection for intravenous (IV) use as an iron replacement therapy for...

Pharma Live:  Jul 2 2009 4:26AM
Matching: anemia
Find similar documents
HTML
100%
FDA Approves Feraheme? to Treat Iron Deficiency Anemia in Adult Chronic Kidney Disease Patients
LEXINGTON, Mass.--(BUSINESS WIRE)-- AMAG Pharmaceuticals, Inc.

(NASDAQ:AMAG) today announced that the U.S.

Food and Drug Administration (FDA) has granted marketing approval for Feraheme?

(ferumoxytol) Injection for intravenous (IV) use...

Pharmacy Choice:  Jul 1 2009 11:47PM
Matching: anemia
Find similar documents
HTML
100%
Amag Pharmaceuticals wins FDA approval for anemia drug
(Datamonitor via COMTEX) -- Amag Pharmaceuticals, a biopharmaceutical company, has received marketing approval from the FDA for Feraheme injection for intravenous use as an iron replacement therapy for the treatment of iron deficiency ...
Pharmacy Choice:  Jul 1 2009 11:52PM
Matching: anemia
Find similar documents
HTML
100%
FDA Gives OK To Anemia Drug
(New York, NY) -- The maker of the injectable anemia medicine Feraheme says the Food and Drug Administration has given its approval to the drug.

AMAG Pharmaceuticals says Feraheme will be available to patients by the second half of...

OzarksFirst.com:  Jul 1 2009 11:55PM
Matching: anemia
Find similar documents
HTML
100%
Ferumoxytol Approved to Treat Iron Deficiency Anemia in Chronic Kidney Disease
_ Ferumoxytol Approved to Treat Iron Deficiency Anemia in Chronic Kidney Disease.
Womens Health:  Jul 2 2009 10:38PM
Matching: anemia
Find similar documents
HTML
100%
Ferumoxytol Approved to Treat Iron Deficiency Anemia in Chronic Kidney Disease
_ Ferumoxytol Approved to Treat Iron Deficiency Anemia in Chronic Kidney Disease.
Medscape:  Jul 2 2009 9:22PM
Matching: anemia
Find similar documents
HTML
100%
Ferumoxytol Approved to Treat Iron Deficiency Anemia in Chronic Kidney Disease
_ Ferumoxytol Approved to Treat Iron Deficiency Anemia in Chronic Kidney Disease.
Abstracts in Hematology and Oncology:  Jul 2 2009 8:49PM
Matching: anemia
Find similar documents
HTML
100%
AMAG Anemia Drug Wins US Approval, Shares Jump
AMAG Pharmaceuticals Inc said U.S.

AMAG Anemia Drug Wins US Approval, Shares Jump.

FDA News:  Jul 2 2009 10:05AM
Matching: anemia
Find similar documents
HTML
100%
BioWorld Today July 1, 2009
It was a day late - but AMAG Pharmaceuticals Inc.

will hardly end up any dollars short.

Aftermarket word Tuesday that the FDA approved AMAG's Feraheme as an iron replacement therapy sent relief through some quarters, though...

Pharmacy Choice:  Jul 1 2009 11:51PM
Matching: anemia
Find similar documents
HTML
100%
Zacks Bull and Bear of the Day Highlights: AMAG Pharmaceuticals Inc., Palm, Inc. Everest Re, Ace Limited and M
ity Research highlights AMAG Pharmaceuticals Inc.

(Nasdaq: AMAG | Quote | Chart | News | PowerRating) as the Bull of the Day and Palm, Inc.

(Nasdaq: PALM | Quote | Chart | News | PowerRating) the Bear of the Day.

In addition, Zacks...

TradingMarkets:  Jul 2 2009 9:56PM
Matching: anemia
Find similar documents
HTML
100%
Zacks Bull and Bear of the Day Highlights: AMAG Pharmaceuticals Inc., Palm, Inc. Everest Re, Ace Limited and M
http://www.profit.zacks.com/ CHICAGO--(Business Wire)-- Zacks Equity Research highlights AMAG Pharmaceuticals Inc.

(Nasdaq: AMAG) as the Bull of the Day and Palm, Inc.

(Nasdaq:PALM) the Bear of the Day.

In addition, Zacks Equity...

Reuters:  Jul 2 2009 9:30PM
Matching: anemia
Find similar documents
HTML
100%
Zacks Bull and Bear of the Day Highlights: AMAG Pharmaceuticals Inc., Palm, Inc. Everest Re,
BusinessWire - Zacks Equity Research highlights AMAG Pharmaceuticals Inc.

(Nasdaq: AMAG) as the Bull of the Day and Palm, Inc.

(Nasdaq: PALM) the Bear of the Day.

In addition, Zacks Equity Research provides analysis on Everest Re (NYSE...

Forbes.com:  Jul 2 2009 9:29PM
Matching: anemia
Find similar documents
HTML
100%
Zacks Bull and Bear of the Day Highlights: AMAG Pharmaceuticals
highlights AMAG Pharmaceuticals Inc.

(Nasdaq: AMAG) as the and Palm, Inc.

(Nasdaq:PALM) the.

In addition, provides analysis on Everest Re (NYSE:RE), Ace Limited (NYSE:ACE) and Montpelier (NYSE:MRH).

Full analysis of all these stocks...

Business Wire via MSN Money:  Jul 2 2009 9:20PM
Matching: anemia
Find similar documents
HTML
100%
Zacks Bull and Bear of the Day Highlights: AMAG Pharmaceuticals Inc., Palm, Inc. Everest Re, Ace Limited and M
CHICAGO--(BUSINESS WIRE)-- highlights AMAG Pharmaceuticals Inc.

(Nasdaq: AMAG) as the and Palm, Inc.

(Nasdaq: PALM) the.

In addition, provides analysis on Everest Re (NYSE: RE), Ace Limited (NYSE: ACE) and Montpelier (NYSE: MRH).

Yahoo! Canada:  Jul 2 2009 9:18PM
Matching: anemia
Find similar documents
HTML
100%
Zacks Bull and Bear of the Day Highlights: AMAG Pharmaceuticals Inc., Palm, Inc. Everest Re, Ace Limited and M
CHICAGO--(BUSINESS WIRE)-- highlights AMAG Pharmaceuticals Inc.

(Nasdaq: AMAG) as the and Palm, Inc.

(Nasdaq: PALM) the.

In addition, provides analysis on Everest Re (NYSE: RE), Ace Limited (NYSE: ACE) and Montpelier (NYSE: MRH).

Business Wire UK:  Jul 2 2009 9:12PM
Matching: anemia
Find similar documents
HTML
100%
Zacks Bull and Bear of the Day Highlights: AMAG Pharmaceuticals Inc., Palm, Inc. Everest Re, Ace Limited and M
CHICAGO--(BUSINESS WIRE)-- highlights AMAG Pharmaceuticals Inc.

(Nasdaq: AMAG) as the and Palm, Inc.

(Nasdaq: PALM) the.

In addition, provides analysis on Everest Re (NYSE: RE), Ace Limited (NYSE: ACE) and Montpelier (NYSE: MRH).

Business Wire via Yahoo!:  Jul 2 2009 9:10PM
Matching: anemia
Find similar documents
HTML
100%
Zacks Bull and Bear of the Day Highlights: AMAG Pharmaceuticals Inc., Palm, Inc. Everest Re, Ace Limited and M
Zacks Equity Research highlights AMAG Pharmaceuticals Inc.

( NASDAQ:AMAG) as the Bull of the Day and Palm, Inc.

( NASDAQ:PALM) the Bear of the Day.

In addition, Zacks Equity Research provides analysis on Everest Re ( NYSE:RE), Ace...

RBC Dain Raushcer:  Jul 2 2009 9:08PM
Matching: anemia
Find similar documents
HTML
100%
Zacks Bull and Bear of the Day Highlights: AMAG Pharmaceuticals Inc., Palm, Inc. Everest Re, Ace Limited and M
Zacks Bull and Highlights: AMAG Pharmaceuticals Inc., Palm, Inc.

Everest Re, Ace Limited and Montpelier http://www.profit.zacks.com/ CHICAGO--(BUSINESS WIRE)-- highlights AMAG Pharmaceuticals Inc.

(Nasdaq: AMAG) as the and Palm, Inc.

...

Business Wire:  Jul 2 2009 9:06PM
Matching: anemia
Find similar documents


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2009 - BioPortfolio Limited.